The biosynthesis of human acid ceramidase (hAC) starts with the expression
of a single precursor polypeptide of similar to 53-55 kDa, which is subsequ
ently processed to the mature, heterodimeric enzyme (40 + 13 kDa) in the en
dosomes/lysosomes. Secretion of hAC by either fibroblasts or acid ceramidas
e cDNA-transfected COS cells is extraordinarily low. Both lysosomal targeti
ng and endocytosis critically depend on a functional mannose 6-phosphate re
ceptor as judged by the following criteria: (i) hAC-precursor secretion by
NH4Cl-treated fibroblasts and I-cell disease fibroblasts, (ii) inhibition o
f the formation of mature heterodimeric hAC in NH4Cl-treated fibroblasts or
in I-cell disease fibroblasts, and (iii) blocked endocytosis of hAC precur
sor by mannose 6-phosphate receptor-deficient fibroblasts or the addition o
f mannose 6-phosphate. The influence of the six individual potential N-glyc
osylation sites of human acid ceramidase on targeting, processing, and cata
lytic activity was determined by site-directed mutagenesis. Five glycosylat
ion sites (sites 1-5 from the N terminus) are used. The elimination of site
s 2, 4, and 6 has no influence on lysosomal processing or enzymatic activit
y of recombinant ceramidase. The removal of sites 1, 3, and 5 inhibits the
formation of the heterodimeric enzyme form. None of the mutant ceramidases
gave rise to an increased rate of secretion, suggesting that lysosomal targ
eting does not depend on one single carbohydrate chain.